The Wertman Method

Dementia and Alzheimer's have emerged as the defining health challenges of our generation. Every three seconds, someone new is diagnosed globally; in Israel, hundreds of thousands are living with the disease and over 50 million worldwide Families are forced to navigate the devastating reality of memory loss, functional and behavioral declines, and staggering costs—often without a shred of hope. Despite these figures, a definitive cure remains elusive. The Or Ad Foundation was established to change this reality. Based on the groundbreaking methodology developed by Prof. Eli Wertman, a clear scientific truth has been revealed: in many cases, it is possible to halt deterioration, alleviate symptoms, and even achieve significant cognitive improvement. Prof. Wertman’s precision diagnosis method refined through the treatment of over 5,000 patients—uncovers what the standard medical community often overlooks. Behind the "Dementia" label frequently lie hundreds of treatable remediable medical conditions affecting brain functionality. Just to mention a few: sleep disorders, diabetes, unbalanced blood pressure, contrasting medicines nutritional deficiencies, mental health challenges and many more. When these factors are identified through the implementation of Prof. Wertman’s method and addressed, the clinical picture might be changed. In a sample of 100 patients, Prof. Wertman found that each of suffered from at least two remediable conditions, and on average over nine conditions. A satisfaction survey of 99 patients revealed: • 55% reported significant improvement in daily functioning. • 41% returned to active social engagement. • 32% showed marked cognitive improvement. Following the publication of the scientific article in the Journal of Clinical Medicine (2024), the medical community was nearly unanimous: “This is a groundbreaking method.” Now, the time has come to institutionalize this change and offer hope to hundreds of thousands. The Or Ad Association has taken upon itself this historic mission: conducting a clinical trial that will establish this method as an international standard. Clinical trials involve significant costs- the cost per patient is approximately 24,000 NIS (approx. $6,500). Together, we can transform the future for thousands of seniors, moving from a future of fear and uncertainty to one of possibility, control, and hope. By doing so, we provide much-needed relief to their families and loved ones. Dementia is not an inevitable part of aging. With the right diagnosis and personalized treatment, an entire life trajectory can be changed. To the Or-ad website Click here 📞 For more information about the projects, or if you have additional ways to help, please feel free to reach out: Nina Hersztain Shitrit — 050-2726554